Lifeward (NASDAQ:LFWD) Given New $10.00 Price Target at HC Wainwright

Lifeward (NASDAQ:LFWD) had its price objective lifted by HC Wainwright to $10.00 in a report published on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Lifeward has a consensus rating of “Hold” and a consensus target price of $10.00.

Lifeward Price Performance

Shares of NASDAQ LFWD opened at $6.82 on Thursday. The stock has a market capitalization of $10.37 million, a PE ratio of -0.37 and a beta of 0.12. The business has a fifty day moving average price of $6.92 and a two-hundred day moving average price of $7.41. Lifeward has a fifty-two week low of $4.14 and a fifty-two week high of $23.04.

Lifeward (NASDAQ:LFWD) last released its earnings results on Wednesday, March 18th. The company reported ($3.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($3.53). Lifeward had a negative return on equity of 128.97% and a negative net margin of 90.38%.The company had revenue of $5.08 million for the quarter, compared to analyst estimates of $7.87 million. On average, equities analysts expect that Lifeward will post -1.78 EPS for the current year.

Institutional Investors Weigh In On Lifeward

Several institutional investors and hedge funds have recently added to or reduced their stakes in LFWD. HRT Financial LP increased its stake in shares of Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after purchasing an additional 29,423 shares during the last quarter. Virtu Financial LLC raised its holdings in shares of Lifeward by 158.0% during the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after buying an additional 37,037 shares in the last quarter. Jane Street Group LLC lifted its position in shares of Lifeward by 77.3% during the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after buying an additional 29,927 shares during the last quarter. Finally, Citadel Advisors LLC lifted its position in shares of Lifeward by 1,271.8% during the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after buying an additional 198,406 shares during the last quarter. 26.76% of the stock is currently owned by institutional investors.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.